Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022:272:165-179.
doi: 10.1007/164_2021_546.

Immunosuppression and Kidney Transplantation

Jeanne Kamal  1 , Alden Doyle  2
Affiliations
Review

Immunosuppression and Kidney Transplantation

Jeanne Kamal et al. Handb Exp Pharmacol. 2022.

Abstract

Immunosuppression is complex, fraught with on-target and off-target adverse effects, and hard to get right but is the key to successful allotransplantation. Herein, we review the key immunosuppressive agent classes used for kidney transplant, highlighting mechanisms of action and typical clinical use.

Keywords: Antibody mediation rejection; Calcineurin inhibitors; Immunosuppression; Induction therapy; Kidney transplantation; Rejection; T-cell depleting agents; Transplant protocols.

PubMed Disclaimer

References

    1. Adams A, Goldstein J, Garrett C, Zhang R, Patzer R, Newell K et al (2017) Belatacept combined with transient calcineurin inhibitor therapy prevents rejection and promotes improved long-term renal allograft function. Am J Transplant 17(11):2922–2936 - PubMed - PMC - DOI
    1. Alinari L, Lapalombella R, Andritsos L, Baiocchi R, Lin T, Byrd J (2007) Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. Oncogene 26(25):3644–3653 - PubMed - DOI
    1. Arriens C, Polyakova S, Adzerikho I, Randhawa S, Solomons N (2020) OP0277 Aurora phase 3 study demonstrates voclosporin statistical superiority over standard of care in lupus nephritis (LN). BMJ Publishing Group - DOI
    1. Barbarino JM, Staatz CE, Venkataramanan R, Klein TE, Altman RB (2013) PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genomics 23(10):563 - PubMed - PMC - DOI
    1. Berns A, Rubenfeld S, Rymzo WT, Calabro JJ (1972) Hazard of combining allopurinol and thiopurine. N Engl J Med 286(13):730–731 - PubMed

MeSH terms

Substances

LinkOut - more resources